With the rapid advancement of technologies such as microprocessors and sensors, electrosurgical techniques in the medical field have also seen significant improvement. In electrosurgery, large vessel sealing technology is a revolutionary development. Currently, LigaSure-type large vessel sealing devices dominate the market. Among them, ShouLiang-med’s AGISEAL series stands out for its excellent performance and has received widespread acclaim both domestically and internationally. These devices are now widely used in clinical surgical procedures.
In thyroid surgery, the use of energy devices has improved both safety and precision. However, the choice of energy device is a critical consideration for surgeons. Different types of energy devices have their own applications, advantages, and limitations at various stages of surgery—for example, ultrasonic energy devices versus large vessel sealing devices.
Ultrasonic energy devices convert electrical energy at 55.5 kHz into mechanical energy via piezoelectric ceramics. The mechanical vibration is transmitted to the tissue through the blade, causing high-frequency friction. This results in vaporization of water molecules, breakdown of protein hydrogen bonds, cell disruption, tissue separation, protein denaturation, and vessel coagulation. Approved by the U.S. FDA, ultrasonic scalpels can safely seal vessels with diameters under 5 mm. While these devices feature lightweight, compact, and flexible curved-tip designs and are increasingly used in thyroid surgery, it’s important to note that their higher operating temperatures can lead to significant lateral thermal spread—especially near the recurrent laryngeal nerve—posing a risk of postoperative complications due to nerve damage.
Traditional monopolar and bipolar energy devices typically seal vessels by forming an intraluminal coagulum and rely solely on visual cues for energy control. These devices lack a feedback mechanism to monitor output power and impedance, making it difficult to gauge optimal coagulation power and duration.
ShouLiang-med’s independently developed AGISEAL series of advanced energy devices addresses these shortcomings by incorporating a negative feedback detection system. Using enhanced bipolar pressure, AGISEAL denatures and fuses the collagen and fibrin in blood vessels, permanently sealing the lumen. AGISEAL can seal vessels with diameters less than 7 mm, and the sealed vessels can withstand arterial pressures up to three times the normal human level. Additionally, it operates at a lower temperature and produces minimal lateral thermal damage, effectively protecting the recurrent laryngeal nerve and reducing the risk of complications.
With intelligent feedback that accurately senses tissue coagulation levels and precisely regulates optimal coagulation power and time, AGISEAL maximizes surgical safety and has become the preferred energy device for thyroid surgery.